Lifecore Biomedical Inc. (LFCR)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Lifecore Biomedical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Lifecore Biomedical Inc. (LFCR) has returned -54.52% so far this year and -47.16% over the past 12 months. Over the last ten years, LFCR has returned -9.85% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Feb 15, 1996, LFCR's average daily return is +0.07%, while the average monthly return is +0.72%. At this rate, your investment would double in approximately 8.1 years.

Historically, 50% of months were positive and 50% were negative. The best month was May 2023 with a return of +92.7%, while the worst month was Mar 2026 at -48.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 10 months.

On a daily basis, LFCR closed higher 45% of trading days. The best single day was Aug 24, 1999 with a return of +129.6%, while the worst single day was Mar 17, 2023 at -67.3%.

Lifecore Biomedical Inc. has an annualized alpha of 9.28%, beta of 0.80, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since February 16, 1996.

• This stock participated in 121.06% of S&P 500 Index downside but only 68.45% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

LFCR ranks 10 for risk / return — in the bottom 10% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Lifecore Biomedical Inc. (LFCR) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Lifecore Biomedical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Lifecore Biomedical Inc. was 92.05%, occurring on Sep 20, 2002. The portfolio has not yet recovered.

The current Lifecore Biomedical Inc. drawdown is 82.07%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Lifecore Biomedical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Lifecore Biomedical Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.